Local drug delivery system for the treatment of osteomyelitis: In vitro evaluation

References

• Agathopoulos S, Tulyaganov DU, Ventura JMG, Kannan S, Saranti A, Karakassides MA, Ferreira JMF. (2006). Structural analysis and devitrification of glasses based on the CaO-MgO-SiO2 system with B2O3, Na2O, CaF2 and P2O5 additives. J Non-Cryst Solids, 352:322–328.
   Web of Science ®Google Scholar
• Aina V, Perardi A, Bergandi L, Malavasi G, Menabue L, Morterra C et al. (2007). Cytotoxicity of zinc-containing bioactive glasses in contact with human osteoblasts. Chem Biol Interact, 167:207–218.
   PubMed Web of Science ®Google Scholar
• Andrade AL, Souza DM, Vasconcellos WA, Ferreira RV, Domingues RZ. (2009). Tetracycline and/or hydrocortisone incorporation and release by bioactive glasses compounds. J NonCryst Solids, 355:811–816.
   Web of Science ®Google Scholar
• Balamurugan A, Balossier G, Michel J, Kannan S, Benhayoune H, Rebelo AH et al. (2007). Sol gel derived SiO(2)-CaO-MgO-P(2)O(5) bioglass system–preparation and in vitro characterization. J Biomed Mater Res Part B Appl Biomater, 83:546–553.
   PubMed Web of Science ®Google Scholar
• Baldrick P. (2010). The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol, 56:290–299.
   PubMed Web of Science ®Google Scholar
• Bang H-G, Kim S-J, Park S-Y. (2008). Biocompatibility and the physical properties of bio-glass ceramics in the Na2O-CaO-SiO2-P2O5 system with CaF2 and MgF2 additives. J Ceram Process Res, 9:588–590.
   Web of Science ®Google Scholar
• Cekic ND, Milic JR, Savic SD, Savic MM, Jovic Z, Daniels R. (2009). Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles. Drug Dev Ind Pharm, 35:1092–1102.
   PubMed Web of Science ®Google Scholar
• Chevalier E, Viana M, Cazalbou S, Chulia D. (2009). Comparison of low-shear and high-shear granulation processes: effect on implantable calcium phosphate granule properties. Drug Dev Ind Pharm, 35:1255–1263.
   PubMed Web of Science ®Google Scholar
• Czarnobaj K. (2008). Preparation and characterization of silica xerogels as carriers for drugs. Drug Deliv, 15:485–492.
   PubMed Web of Science ®Google Scholar
• El-Ghannam A, Ahmed K, Omran M. (2005). Nanoporous delivery system to treat osteomyelitis and regenerate bone: gentamicin release kinetics and bactericidal effect. J Biomed Mater Res Part B Appl Biomater, 73:277–284.
   PubMed Web of Science ®Google Scholar
• El-Kamel AH, Baddour MM. (2007). Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation. Drug Deliv, 14:349–356.
   PubMed Web of Science ®Google Scholar
• Gu C, Zheng R, Yang Z, Wen A, Wu H, Zhang H et al. (2009). Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growth factor: formulation and characteristics. Drug Dev Ind Pharm, 35:1419–1429.
   PubMed Web of Science ®Google Scholar
• Hing KA. (2005). Bioceramic bone graft substitutes: influence of porosity and chemistry. Int J Appl Ceram Technol, 2:184–199.
   Web of Science ®Google Scholar
• Hughes SP, Anderson FM. (1985). Penetration of antibiotics into bone. J Antimicrob Chemother, 15:517–519.
   PubMed Web of Science ®Google Scholar
• Itokazu M, Ohno T, Tanemori T, Wada E, Kato N, Watanabe K. (1997). Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats. J Med Microbiol, 46:779–783.
   PubMed Web of Science ®Google Scholar
• Kählig H, Hasanovic A, Biruss B, Höller S, Grim J, Valenta C. (2009). Chitosan-glycolic acid: a possible matrix for progesterone delivery into skin. Drug Dev Ind Pharm, 35:997–1002.
   PubMed Web of Science ®Google Scholar
• Kong M, Chen XG, Liu CS, Liu CG, Meng XH, Yu le J. (2008). Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli. Colloids Surf B Biointerfaces, 65:197–202.
   PubMed Web of Science ®Google Scholar
• Kontonasaki E, Zorba T, Papadopoulou L, Pavlidou E, Chatzistavrou X, Paraskevopoulos K, Koidis P. (2002). Hydroxy carbonate apatite formation on particulate bioglass in vitro as a function of time. Cryst Res Technol, 37:1165–1171.
   Web of Science ®Google Scholar
• Kundu B, Soundrapandian C, Nandi SK, Mukherjee P, Dandapat N, Roy S et al. (2010). Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial. Pharm Res, 27:1659–1676.
   PubMed Web of Science ®Google Scholar
• Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q. (2009). Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Drug Dev Ind Pharm, 35:1348–1355.
   PubMed Web of Science ®Google Scholar
• Melville AJ, Rodríguez-Lorenzo LM, Forsythe JS. (2008). Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders. J Mater Sci Mater Med, 19:1187–1195.
   PubMed Web of Science ®Google Scholar
• Nandi SK, Kundu B, Mukherjee P, Mandal TK, Datta S, De DK, Basu D. (2009). In vitro and in vivo release of cefuroxime axetil from bioactive glass as an implantable delivery system in experimental osteomyelitis. Ceram Int, 35:3207–3216.
   Web of Science ®Google Scholar
• NCCLS. (2002). Performance standards for antimicrobial susceptibility testing. NCCLS, Wayne, Pa.
   Google Scholar
• Ouédraogo M, Semdé R, Somé IT, Traoré-Ouédraogo R, Guissou IP, Henschel V et al. (2008). Monoolein-water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization. Drug Dev Ind Pharm, 34:753–760.
   PubMed Web of Science ®Google Scholar
• Park Y, Kim MH, Park SC, Cheong H, Jang MK, Nah JW et al. (2008). Investigation of the antifungal activity and mechanism of action of LMWS-chitosan. J Microbiol Biotechnol, 18:1729–1734.
   PubMed Web of Science ®Google Scholar
• Radev L, Hristov V, Samuneva B, Ivanova D. (2009). Organic/inorganic bioactive materials Part II: in vitro bioactivity of collagen-calcium phosphate silicate/wollastonite hybrids. Cent Eur J Chem, 7:711–720.
   Web of Science ®Google Scholar
• Rossi S, Marciello M, Sandri G, Bonferoni MC, Ferrari F, Caramella C. (2008). Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties. Pharm Dev Technol, 13:513–521.
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Steinhauser H, Rump AF, Berkels R, Pulverer G. (1997). Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials, 18:839–844.
   PubMed Web of Science ®Google Scholar
• Seeley Z, Bandyopadhyay A, Bose S. (2008). Tricalcium phosphate based resorbable ceramics: Influence of NaF and CaO addition. Mat Sci Eng C, 28:11–17.
   Web of Science ®Google Scholar
• Shirtliff ME, Calhoun JH, Mader JT. (2002). Gatifloxacin efficacy in treatment of experimental methicillin-sensitive Staphylococcus aureus-induced osteomyelitis in rabbits. Antimicrob Agents Chemother, 46:231–233.
   PubMed Web of Science ®Google Scholar
• Soundrapandian C, Datta S, Sa B. (2007). Drug-eluting implants for osteomyelitis. Crit Rev Ther Drug Carrier Syst, 24:493–545.
   Google Scholar
• Soundrapandian C, Sa B, Datta S. (2009). Organic-inorganic composites for bone drug delivery. AAPS Pharmscitech, 10:1158–1171.
   PubMed Web of Science ®Google Scholar
• Tian Y, Li L, Gao X, Deng J, Stephens D, Robinson D et al. (2002). The effect of storage temperatures on the in vitro properties of a polyanhydride implant containing gentamicin. Drug Dev Ind Pharm, 28:897–903.
   PubMed Web of Science ®Google Scholar
• Ubaidulla U, Khar RK, Ahmad FJ, Tripathi P. (2009). Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology. Pharm Dev Technol, 14:96–105.
   PubMed Web of Science ®Google Scholar
• Wachol-Drewek Z, Pfeiffer M, Scholl E. (1996). Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials, 17:1733–1738.
   PubMed Web of Science ®Google Scholar
• Xia W, Chang J. (2006). Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release, 110:522–530.
   PubMed Web of Science ®Google Scholar
• Zhao L, Yan X, Zhou X, Zhou L, Wang H, Tang J, Yu C. (2008). Mesoporous bioactive glasses for controlled drug release. Micropor Mesopor Mat, 109:210–215.
   Web of Science ®Google Scholar
• Zhu Y, Kaskel S. (2009). Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Micropor Mesopor Mat, 118:176–182.
   Web of Science ®Google Scholar